In the context of cancer, the ECM undergoes significant alterations that contribute to tumor progression and metastasis. These changes include increased stiffness, altered composition, and enhanced degradation. The remodeling of the ECM is primarily driven by cancer cells and associated stromal cells, which secrete enzymes such as matrix metalloproteinases (MMPs) that degrade ECM components.
